Invizius is a spin-out based on world-class Complement research carried out at the University of Edinburgh, Scotland.
Complement is 1.3b years old and part of the innate immune system. As it is the most ancient part of the immune system it is involved at the beginning of every inflammatory response. We fight inflammation at its source.
Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with dysregulated complement systems leading to inflammation and fibrosis.
Our first indication for H-Guard is in Acute Kidney Injury receiving CRRT where there is filter membrane associated Complement driven damage to renal tubule cells as well as local and systemic inflammatory damage.
Our second product Meso-Guard is for patients on Renal replacement Therapy receiving Peritoneal Dialysis. This product should extend the PD treatment window by reducing fibrotic changes caused by peritoneal dialysis fluid.
Despite significant improvements in haemodialysis membranes Complement activation by contact with a foreign surface remains a serious issue with short, medium and long term clinical implications. Other acute application of H-Guard is for coating Cardiopulmonary Bypass and ECMO filters.
Other applications of our platform include IgA Nephropathy, Preeclampsia, SLE and Neuroinflammation.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Biocity Glasgow, Bo'ness Road,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- invizius.com
- Keywords
- Nephrology, Fibrosis, Neurology, Autoimmunity, Diabetes, Complement, Immunology, Inflammation.
- HQ
- Motherwell, North Lanarkshire
Invizius Questions
Invizius's website is invizius.com
Invizius's LinkedIn profile is https://uk.linkedin.com/company/invizius-limited
Invizius has
12 employees.
View email and phone details for 12
employees at Invizius.
Invizius's industry is
Pharmaceutical Manufacturing
Invizius's top competitors are
Macomics,
Pact,
Ilc Therapeutics,
Fermtech,
Lift Biosciences,
Corryn Biotechnologies,
Neophore Ltd,
Kynos Therapeutics,
Caldan Therapeutics,
Vicebio.
Invizius's categories are Pharmaceutical Manufacturing
Invizius's founding year is 2018
